Cardiac Sonographer – Perth, WA

Position: Cardiac Sonographer 

  • Are you a fully qualified Cardiac Sonographer that is passionate about echocardiography and cardiac diagnostics?
  • Are you wanting to challenge your skills and work as part of a high-performing, industry-leading echo lab?
  • Do you want to work at Australia’s largest private hospital, as part of a growing cardiothoracic service and cutting-edge structural heart program?
  • Do you want to be involved in innovative interventional echocardiography, assisting with procedures such as left atrial appendage occlusion (LAAO), MitraClip, TAVI and more?
  • Are you tired of working with old, out dated echo machines and PACs systems, whilst being expected to conduct shortened studies?
  • Do you care about the quality of your patient’s diagnostic study, and want to pursue the best possible outcomes for your patients?

If you answered “yes” to any of the above, we’d love to discuss this opportunity further with you!
A new opportunity is available for a highly skilled, experienced Cardiac Sonographer to join our highly successful organisation, either on a full-time, part-time, or casual basis. This permanent position will be based across all our Perth sites.

What’s on Offer?

  • Full time, part-time or casual opportunity.
  • Competitive remuneration package.
  • Monday – Friday work, with additional penalty rates for weekend work (when on-call).
  • Work with industry leading facilities, equipment and reporting platforms.
  • Leadership and education from experts in their respective fields.
  • Exposure to cutting edge imaging and treatment modalities – including diagnostic and interventional transoesophageal echocardiography.
  • Contribute to the growing cardiothoracic and interventional service at Hollywood Private Hospital.
  • Clear opportunities for personal and professional development, with contribution towards CPD requirements.

The Position

  • Perform high quality echocardiograms (including stress echo) in CVS outpatient clinics and on hospital wards.
  • Deliver accurate, timely and complete reports to the reviewing Physician.
  • Work closely with all CIS group staff in delivering a holistic approach to patient care.
  • Work alongside experts in cardiology and echocardiography, committed to educating and developing technologists and sonographers.
  • Be part of an integrated, professional organisation committed to delivering an excellent patient experience.

The Successful Candidate will have:

  • ASAR accreditation.
  • At least 12 months’ previous experience as a fully qualified cardiac sonographer.
  • A genuine commitment to contributing to the CIS group and in delivery of our purpose; “to improve the standard of what quality service looks like” by aligning with CIS group values.
  • Pride in the quality and accuracy of their work with a very high attention to detail
  • A professional, friendly and calm manner.
  • Flexibility and the willingness to work at various locations in the Perth Region.
  • A current Driver’s Licence and a reliable vehicle.

Are you ready to make the move?
Include your current CV and cover letter addressed to our Chief Operating Officer, Ian Watts ([email protected]), indicating why you are interested in this position and how you will positively contribute to our CVS team. If anyone is interested in learning more about the role, please feel free to email to organise a time for a confidential, informal chat.

Cardiology Research Reviews Issue 162, with commentary by A/Prof John Amerena

In this edition:

–  Long-term efficacy of evolocumab in patients with or without multivessel coronary disease
–  DAPT de-escalation in stabilised MI patients after PCI
–  Risk of postoperative mortality in patients with a previous cardiovascular event
–  Physical activity and weight loss among overweight or obese adults with T2D
–  AI model for predicting malignant ventricular arrhythmias in patients with an ICD
–  AI model predicts undiagnosed AF in patients with ESUS
–  Apixaban for stroke prevention in subclinical AF
–  Pulmonary vein isolation ± left atrial appendage ligation in AF
–  Sex-specific association between perivascular inflammation and plaque vulnerability
–  SGLT2 inhibitors influence skeletal muscle pathology in patients with HFrEF

Download the Cardiology Research Review Issue 162 here (pdf)

Interventional Cardiologist, Whangārei Hospital

Position: Interventional Cardiologist

  • Permanent, full-time Consultant role (1.0 FTE)
  • Whangārei, New Zealand
  • Join a growing team and service

Te Whatu Ora, Te Tai Tokerau is committed to Te Tiriti o Waitangi and holds stewardship for equitable health outcomes for Māori as Tāngata Whenua as the highest priority.

We are seeking an Interventional Cardiologist to deliver clinical care across Cardiology services in the Cath Lab and in outpatient clinics. This position will be one of three interventional cardiologists in Whangārei Hospital providing a thorough and comprehensive cardiology service. The service currently provides diagnostic imaging modalities; Cardiac MRI, CTCA & 3D echo. Pacing is not currently provided however we would be very open to hear from those with this type of experience.

Whangārei Hospital is the largest hospital in Northland, providing secondary care services across the region and supported by three rural hospitals in Dargaville, Kaitaia and the Bay of Islands. Whilst this position is pre-dominantly based in Whangārei, the successful candidate will also work in rural areas from outpatient clinics as needed. Currently there is no on-call commitment, however as we are a growing service, this will change once an inpatient service is established.

As an Interventional Cardiologist you will join a small but close-knit team dedicated to their patients. You will bring your specialist experience and embrace the challenges involved in developing the service to its maximum potential. You will be a motivated team player that is patient focused. You will play a key part in the development of the service in order to improve access to cardiac care for a region that has historically been undeserved.

To be considered, you must have or be eligible for vocational registration in an Internal Medicine (Cardiology) scope of practice with the Medical Council of NZ and have completed interventional cardiology training. Advanced cardiology training is essential and those with pacing skills would be advantageous to the growth of the service.

For more information about the MCNZ registration process, please visit www.mcnz.org.nz

We offer a competitive relocation package to support you and your family to make the move to Whangārei. Te Whatu Ora is also an Approved Accredited Employer by the New Zealand Immigration Service and can assist you to obtain an appropriate visa.

To submit your application, please apply via the online application portal below ensuring to submit an up-to-date CV and cover letter. For assistance with the application process or if you have any queries, please contact [email protected]  referencing vacancy number: MD23-042

Job Description

General Cardiologist – Northland

Position: General Cardiologist

A randomised controlled trial of Early valve replacement in severe ASYmptomatic Aortic Stenosis

A new clinical trial called EASY-AS (A randomised controlled trial of Early valve replacement in severe ASYmptomatic Aortic Stenosis). EASY-AS is a non-commercial clinical trial funded by the Australian Government’s Medical Research Future Fund and is looking to randomise patients with severe but asymptomatic aortic stenosis to either have their aortic valve replaced early in the absence of symptoms, or the usual pathway of valve replacement if and when symptoms present.

Download the EASY-AS Clinician Flyer v4.0 28-03-2023 to read more about the trial and how to get involved or scan the QR code below.

SURVEY | Prescribing blood pressure-lowering medicines to older adults

What factors influence your decision to prescribe blood pressure-lowering medicines to older adults?

Researchers at Westmead Applied Research Centre and The University of Sydney are recruiting doctors who work in Australia and who manage older people with high blood pressure.

Synopsis

Increasing falls, social isolation, and polypharmacy are common concerns clinicians have in up titrating antihypertensive medicines for older patients. In this study using a discrete choice experiment(DCE), I will examine clinicians’ trade-offs when deciding to up-titrate antihypertensive medicines when BP is not in control.

Click on the link below to answer a short series of questions including a hypothetical choice experiment. (20-30 mins duration). There is no cost associated with participation in this research study, we will reimburse you for your time.

ACCESS THE SURVEY HERE or scan the QR Code

If you would like more information, please contact: Edel O’Hagan.
If you have any questions about this research and would like to contact the chief investigator please contact: Prof Clara Chow.

HREC Approval Number: HC 2022/718                     Version dated: 05 09 2022

Congratulations to the Editorial Fellows appointed to Heart Lung and Circulation for 2024

Congratulations to the Editorial Fellows appointed to Heart Lung and Circulation for 2024:

Dr Mohammed Al-Omary (NSW), Dr Katherine Bate (NSW), Dr Sinjini Biswas (Vic), Dr Georgia Chaseling (NSW), Dr Hong Chew (NSW), Dr Kenneth Cho (NSW), Dr Jonathan Ciofani (NSW), Dr Avedis Ekmejian (NSW), Dr Hannah Kempton (NSW), Dr Nick Lan (WA), Dr Julee McDonagh (NSW) and Dr Varun Sharma (Vic).

The Heart Lung and Circulation (HLC) Editorial Fellow position is a 12-month honorary appointment to provide aspiring researchers and/or clinician-researchers direct experience working with HLC’s Editorial Boards. The Editorial Fellows will be introduced to a broad range of aspects of academic publishing to encourage ongoing scholarship and involvement with academic scientific journals.

Heart Failure Research Review, Issue 84, with commentary by Dr Mark Nolan

In this edition

–  Use of clinical and echocardiographic evaluation to assess HF risk
–  Optimisation of evidence-based HF medications after acute admission
–  Implantable haemodynamic monitors improve survival in HFREF
–  Neuropeptide Y: elevated in HF and predicts outcomes
–  Bariatric surgery and weight-loss pharmacotherapies in HF with obesity
–  Prognostic value of HGI in HFREF
–  GFR decline after dapagliflozin in HFMREF/HFPEF
–  First-phase EF predicts adverse outcomes in HF
–  CV medication utilisation trends among US veterans with HF or CAD + diabetes

Download the Heart Failure Research Review here

SPOTLIGHT ON : Women in Cardiology (WiC) Working Group

Did you know that we have a vibrant and enthusiastic Working Group dedicated to improving equity for women at all levels of the career journey?   

Our goal is to engage a higher representation of women in Cardiology, given we have the lowest level of representation amongst all Medical specialties. Currently, only 15% of all cardiologists are women, with only 5% specialising as interventional cardiologists.

Chair:  Dr Sonya Burgess, an interventional cardiologist based in Sydney.

Steering Committee:  Dr Sarah Zaman, Dr Clara Chow, Dr Anastasia Mihailidou, Dr Rebecca Kozor, Dr Swati Mukherjee, Dr Belinda Gray, Dr Elizabeth Shaw, Dr Ruth Arnold, Dr Alicia Chan, Dr Cara Barnes, Dr Louise Segan, Dr Jain Manali, Dr Anastasia Vlachadis-Castles, Dr Lynne Pressley and Dr Rebecca Jedwab.

The focus of the Working Group is to have the CSANZ Board, and members, to support women and improve representation of women in cardiology at all levels – from conference invitations to committee membership, policies, equity and future leaders.

There are plans to coordinate preparing a WiC day focused on interview skills CV preparation for advanced trainee, fellowships, and early career positions, with a workshop and skills day led by Dr Rebecca Kozor and Dr Sonya Burgess.

We also wish to encourage having a network where the offline conversations, mentoring, and sponsorship can grow.

We look forward to welcoming you to our WiC Working Group.  There are no exclusions!  If you are interested to join us on our mission, please contact:  [email protected]  or contact her via the Nepean Hospital on +612 4734 2000.

One of the most rewarding changes we have seen, as we try to achieve more equity and diversity in cardiology, is that it generates mentoring and support. We have had women in Cardiology at all levels reaching out to members of this group with questions, requests for data, support and further plans for research and networking.

In Australia and New Zealand, women are still under-represented at trainee level and published modelling, based on Australian data, suggests the rate of change is underwhelming. We currently are unlikely to reach gender parity for at least 50 years, and our rate of change is worse than that of Surgery.  

There is longstanding evidence of inequity for women seeking careers in Cardiology.

Research shows women are under-represented at consultant, trainee level and professor promotion. Research also shows that in Cardiology we have ongoing cultural issues, including conscious and unconscious bias, that as a specialty we are yet to successfully address. These issues have an impact on outcomes for our colleagues, trainees, students and patients.

Importantly, changes are happening, in individual departments and hospitals throughout our countries, in our policies and systems, and in our conference committees as we all try to facilitate positive change.

One recent example of a WiC initiative supported by NSW cardiology heads of department, led by Dr Tom Ford, were changes to the under-representation of women at the Heads of Department “cull meeting” . This meeting considers, grades, and ranks all applicants for Advanced Training positions in Cardiology for advanced trainee positions in New South Wales. Of the large 12-15 person voting panel, there was only one-woman representative. As NSW health policy for recruitment and training aims to avoid poor representation of women on interview panels by stipulating on a 5-person panel, at least one voting panellist should be a man, and at least one person should be a woman. The CSANZ WiC group requested that for the panels, such as the cull meeting, that similar minimal ratios should be sought and the voting committee members should not be greater than 80% male (or greater than 80% female), based on the minimum 1:4 ratio within NSW policy. The CSANZ WiC group worked together with Dr Tom Ford (who chairs this meeting) and all of the Department Heads, which led to greater than 20% of the panel for were women this year for the first time. 

As a group, we are working on increasing visibility on the both the national and international stage, to provide supportive role models for the next generation of not only Cardiology trainees but all women in cardiology, including nursing, allied health and research and more equity focused research and research funding.

In 2023, we have seen members of our steering committee actively working on these goals. Our proudest moments come when we see our trainees/mentees/students doing well and breaking their own glass ceilings.

For example, in 2024 Dr Roopa Krishnamoorthy will become the first female advanced trainee to take up an interventional cardiology fellowship at Nepean Hospital, and start her journey in interventional cardiology.

Our Steering Committee members are recognised both at national & international levels, and are recognised leaders in the Cardiology field or rising stars.
  • Dr Sonya Burgess, Chair WiC group, presented as faculty at TCT2023, one of the premier interventional congresses and had her STEMI papers cited in 2023 ESC guidelines, co-authored an EAPCI position paper on radiation safety (1) and secured funding and started early data collection for occupational radiation safety in pregnancy research.
  • Dr Sarah Zaman is invited as one of 21 Lancet Commissioners on the Lancet Commission on Atherosclerotic Heart Disease and has been included in CSANZ STEMI guideline committee.
  • Dr Elizabeth Shaw, our first Australian interventional cardiologist to perform TAVI has now also become the second female Head of Cardiology Department in New South Wales.
  • Dr Anastasia Mihailidou was invited Discussant at the American Heart Association Late Breaking Science this year and Keynote presentation at the 10th National Prevention Conference in Ireland. She also was one of the invited Faculty to review the content for the World Health Organisation technical specifications for pre-market assessment of blood pressure measuring devices (2).
  • Dr Ruth Arnold was the first female Head of department of Cardiology at Orange Health Service and successfully lead the initiative to include more women at the head of department cull meeting. Dr Arnold received an OAM for services to rural cardiology. With her colleague Dr David Amos, she has worked to establish an accredited rural advanced trainee position based at Orange and linked to RPAH. This is the first rural hospital to be able to recruit advanced trainees. She is hoping to expand the rurally based training program across western NSW.   
  • Dr Clara Chow received an OAM for her service to medicine and research, and was appointed as a new Fellow by The Australian Academy of Health and Medical Sciences and was Digital Health Technology Award Finalist.
  • Dr Rebecca Jedwab is a Critical Care Registered Nurse and PhD (Nursing) graduate from Deakin University. She is a Fellow of the Australian College of Nursing and passionate about advancing mentorship, professional development and research within her healthcare organisation.
  • Dr Louise Segan received the Baker Heart and Diabetes Institute Bright Sparks Scholarship Recipient and Baker Research Forum quarterly prize winner as well as APHRS Young Investigator Award 2023. Louise is one of our rising shining stars with having first author on original research published in European Heart Journal this year (3). 
  • Dr Alicia Chan is a co-author of the Australian Consensus on the Management of Heart Failure, active in the heart failure and pacing/cardiac devices space and is a board member of CSANZ and National Heart Foundation (SA).
  • Dr Belinda Gray is current Chair of the CSANZ genetics council and Heart Foundation Future Leader. Dr Gray was also the Australian lead and only Australian author for the recent LIVE-HCM- large multicentre international study assessing safety of vigorous exercise in hypertrophic cardiomyopathy which will bring change in clinical practice (4).
  • Dr Swati Mukheriee is the first woman of colour to qualify as an interventional cardiologist in Australia and New Zealand, and the first female interventionalist to be awarded a prestigious SCAl-USA Fellowship in recognition of interventional cardiology excellence. Dr Mukherjee is co- chair of the CSANZ Equity, Diversity and Culture Committee and member of Gender Equity in Medicine Committee of the Royal Australian College of Physicians (RACP).

References
1. Manzo-Silberman S, Velázquez M, Burgess S, et al (2023). Radiation protection for healthcare professionals working in catheterisation laboratories during pregnancy: a statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the European Heart Rhythm Association (EHRA), the European Association of Cardiovascular Imaging (EACVI), the ESC Regulatory Affairs Committee and Women as One. EuroIntervention; 19(1):53-62. 

2. WHO (2023). Technical specifications for pre-market assessment of blood pressure measuring device with cuff, automated and semi-automated. 

3. Segan L et al. (2023) New-onset atrial fibrillation prediction: the HARMS2-AF risk score. Eur Heart J; 44:3443-3452 

4. Lampert R, Ackerman MJ, Marino BS, Burg M, Ainsworth B, Salberg L, Tome Esteban MT, Ho CY, Abraham R, Balaji S, Barth C, Berul CI, Bos M, Cannom D, Choudhury L, Concannon M, Cooper R, Czosek RJ, Dubin AM, Dziura J, Eidem B, Emery MS, Estes NAM, Etheridge SP, Geske JB, Gray B, Hall K, Harmon KG, James CA, Lal AK, Law IH, Li F, Link MS, McKenna WJ, Molossi S, Olshansky B, Ommen SR, Saarel EV, Saberi S, Simone L, Tomaselli G, Ware JS, Zipes DP, Day SM; LIVE Consortium. Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy. JAMA Cardiol. 2023;8(6):595-605   

Posts navigation